Valo Health to Participate in Piper Sandler's Spring Biotech Symposium
Valo Health, Inc (“Valo”), the technology company focused on transforming the drug discovery and development process using human-centric data and artificial intelligence-powered compute, announced that its founder and CEO, David Berry, will participate in the Piper Sandler Spring Biotech Symposium, on May 3rd in Cambridge, MA.